Meeting · chair Margaret

brief 06-17. no trades between meetings — book is exactly where we left it. nav 981,015, 9 names. the surprise on the tape since last sit-down: cme bled -5.09pct, -13bps total / -8.5bps active, the single biggest drag; pep cracked -2.01pct so it's now under water through its fill. v carried the book, +2.03pct and the only green name. concentration reads 90.88pct top-5 / 86pct top-3 but it's the 80.3pct spy core, not a name-level drift — gate's direction-aware, nothing to trip. the one line i flag every time: cash 4,012 = 0.41pct nav, under the 2pct floor, the un-swept sgov residual — zero t+1 buffer, any buy needs an spy trim to print first. no rejects, no halts, no breaks. handing back to the chair.

Rates: 10yr 4.43 (from 4.47), 10-year reals 2.14 — second straight downtick off the 2.21 cycle high but still firmly restrictive and >2.10, so low-vol stays ON, NOT through my 1.90 ease trigger. The story this week is the front-to-belly flattening: 2s10s collapsed to 29bps today from 39, the 2y holding 4.05 while the long end rallies. The steepener stalled and is reversing — that's the market pulling cuts forward, not pricing growth. Funds 3.63 parked, Fed on hold.

Dollar/oil: broad USD eased back through 120 to 119.5 — no fresh deval impulse. WTI is the real mover: $84.65 from ~$95, down hard over two weeks. That deflates the energy-hedge accelerant and takes pressure off headline — but core/services stickiness is the inflation I'm watching, and oil rolling doesn't fix shelter.

Credit/vol: OAS 271, tightened again — credit dead complacent, no fraying. VIX 18.4, the early-June pop fully faded. Still equity-vol, not credit stress.

What changed: oil down ~11%, curve flattening, reals grinding lower. The squeeze is easing at the margin but the structure holds — restrictive reals + complacent credit. Tilt unchanged: low-vol ON, cash-flow over multiple, quality over junk. The label I'd use today: late-cycle defensive, restrictive but at the margin softening.

Gross: stay fully invested, ~99.6% — cash is residual, no change. The real number that matters is active gross: only ~20%. 80% sits in the SPY dead core that's bled -161.5bps inception. That's the lever, not which defensive notch we hold.

Regime (riding Priya's 06-18): late-cycle, restrictive reals 2.14 — second downtick but >2.10, low-vol stays ON. OAS 271 complacent, VIX 18.4 faded, WTI rolled -11% to $84.65. Late-cycle defensive, softening at the margin. Not a turn.

Factor tilt I'm sponsoring: low-vol + cash-flow-today over multiple. Quality over junk. Unchanged.

The structural wall, named again: book beta 0.911, one tick off the 0.90 floor. The ONLY high-beta active leg is ETN (1.24) — a detractor I won't lever into rolling oil + restrictive reals. So every defensive name Margaret wants seats under 0.90 solo. Fund from the SPY core, not ETN — gate is direction-aware, trimming beta-1.0 to add a low-vol leg is the clean path to ≥0.90.

Where I'm happy / where I want it to move:

• Financials +5.5pp over SPY, band-binding — don't add. CME (-13bps, top drag) and SPGI are the bleed; V (+15.7bps active) carries the sleeve.
• Energy 1.1pp over with WTI rolling — XOM the hedge is deflating (-6.7bps active). Don't add cyclical into falling oil.
• Move: rotate SPY → one named low-vol/cash-flow leg toward the 18-name floor (we're at 9). Margaret's name to source, mine to size+pair ≥0.90 funded by a SPY trim.

Triggers unchanged: OAS>350 → trim ETN/cyclical first; reals<1.90 + 10yr<4.30 → eases low-vol, migrates ETN right-side.

The risk envelope, plainly. The one hard gate is the single-name cap, 0.5%–3.5% of NAV (single_name_weight_band). Nothing is creeping toward it: V is the largest active name at 3.15%, ~35bps of headroom, and no other active position is above 2.6%. The top-5 at 90.9% is optics — it's SPY plus four ~2.5% names, not a concentrated bet. We have room on the gate to build the active sleeve.

What policy WON'T catch and the committee owns: Financials at 18.5% is ~1.43x SPY (inside the 1.6x sector cap, but a third Financial name near 2.5% trips it), and Staples 9.2% is ~1.5x. Both are deliberate tilts — fine, but own them on purpose. CME is the live wound: down -4.05% from fill, -10.1bps inception, the single biggest active detractor. If CME prints and gaps -15%, that's ~37bps of NAV / ~$3.6k — bounded, and ~1140bps from the -2000bps review line.

Two standing items unchanged: cash 0.41%, under the 2% floor with zero T+1 settlement buffer — any active add must be funded by a same-day SPY trim that prints first or it fails. Book beta 0.911 is pinned on the floor; every cash-flow name the frame wants pushes it down, so fund low-vol adds from the SPY core, not the ETN lever. Mid-week trigger to call a flag: OAS through 350 (currently 271) turns the VIX into a risk-off, and I trim the 1.24-beta ETN first.

VOTE: abstain

Two reads from me, both about thesis quality, not pitches.

First, the theme holds and Priya's tape confirms it: cash-flow yield the market has divorced from the franchise, low-vol, outside the Financials sleeve. With oil rolling ~11% to $84.65, the energy-hedge leg is deflating — XOM is my worst inception detractor (-5.3%, -6.7bps active) and I'm not adding to it; the hedge thesis is softening at the margin. The cleaner expression is staples/health-care cash compounders, where I'm hunting next.

Second, conviction moves. CME bled -5.09% but that's a surprise CEO transition, not an earnings or volume impairment — the franchise (open-interest moat, rate-vol tailwind) is intact, so I'm holding, not trimming on a headline. GIS is now -1.4% through fill and still band-capped at 2.0%; thesis intact, the only wall is the Staples cap. GILD stays my off-book WATCH — wanted it toward $121 on the prior pullback; I'll re-check the tape in PROPOSE. ABBV still re-rated, want $205-210. No conviction degraded on the fundamentals — only the energy leg's role in the frame.

On PEP → 1.3%: I'm the name's sponsor, so I'll be plain. PEP sits 2.40%, -2.01% through fill, ~0bps active — a dead-weight low-vol leg, not a dislocation. The trim to 1.3% clears the gate with no breaches, and it's the honest funding source: it reallocates within the same cash-flow/low-vol factor toward the cheaper, deeper name. The franchise is intact — this is a sizing call, not a thesis kill. The only reason to free that ~110bps is if it seats something better — GILD's second 1.0% or a fresh dislocation. I won't trim into thin air. If the room has the redeployment lined up, I support 1.3%; if it's a trim for trim's sake, carry 2.40%. Vote it on whether the dollars have a home today.

Macro-PASS on PEP→1.3%, leaning approve as funding. This isn't a tilt change — the trim reallocates within the same low-vol cash-flow factor, out of a dead-weight notch (-2.01% through fill, ~0bps active) into fresh GILD breadth. Staples already sits +3.2pp over SPY, so trimming the over-tilt and seating a new defensive name is frame-consistent, not a low-vol unwind. Frame holds: reals 2.14 still >2.10 (low-vol ON), 2s10s flattened to 29, OAS 271 dead complacent, WTI rolling to $84.65. The deeper funding source for breadth is still the 80% SPY core, not Staples — but I won't stand in front of a clean within-factor reallocation.

PEP 2.40%→1.3% is a trim. It clears the gate with no breaches, and a trim only reduces what we're carrying — single-name down, Staples sector weight down (which sits +3.2pp over SPY, so this eases that tilt, doesn't worsen it). The remaining ~1.3% line is roughly $12.7k of NAV; a -15% gap on it is ~$1.9k, about 19bps, and the -15% relative stop caps it. There is no breached limit and no unwearable loss on a position we're cutting — nothing here is mine to block. Whether trimming a flat dead-weight notch into fresh GILD breadth is the right use of the funds is selection, not risk; Margaret sponsors it and Daniel/Priya converged. Standing items unchanged: cash 0.41% under the 2% floor means this trim has to settle before the GILD buy funds — sequencing, ops' wrinkle, not risk. Beta still pinned ~0.91 on the floor; trimming a beta-~0 name barely moves it. VOTE: approve

pep 2.40%->1.3% = sell ~76.5sh @ 141.59, ~$10,830 notional; ~90sh held after
the ~$10.8k credit + 4,012 residual is the actual funding for gild 1.0% (~$9,810)
sequence: pep sell prints first, then gild buy — net cash stays positive, no t+1 breach
this trim finally clears the standing sub-floor cash item without an spy trim
no explicit working style on #59 — what's the style, vwap or limit
ops doesn't vote

FILLED — SOLD 77 PEP @ $142.03 (now ~1.30% of NAV), proceeds to cash. Book: 9 names, SPY ~80.3%, cash $14,888. This name is set — no need to re-table it.

VOTE — APPROVE GILD 1.0% (#60). This is my lead name and it finally seats. The franchise is genuine and I won't re-litigate it: FY25 10-K (SEC XBRL) — revenue $29.4B, operating income $10.0B = 39% op margin, net $8.5B / $6.78 diluted, OCF $10.0B, ROE 43%, fwd PE 15.2, 2.6% covered yield, beta 0.33. Bought on a real pullback through the 200d (~$125.45). At 1.0% it's a clearing starter, not a sixth WATCH — a fresh cash-flow defensive that advances the campaign 9→10 names and buys NEW selection breadth, not a PEP/GIS top-up. The PEP credit funds it, cash stays positive, gate clears with no breaches. The second 1.0% I keep pre-committed to a higher-beta active leg that opens the budget — I won't fake it by leaning ETN into reals at 2.14. Kill: FY26 OCF <$11B. Stop -15% rel. Print 08-06. Approve.

Macro-approve GILD 1.0% (#60). Frame held all session and nothing flipped — reals 2.14 (>2.10, low-vol ON, not through 1.90), 2s10s flattened to 29, OAS 271 dead complacent, WTI deflating to $84.65. This is the deployment leg of a clean reallocation within the low-vol cash-flow factor: dead-weight PEP notch out, fresh GILD breadth in (beta 0.33, 39% op margin, $10B OCF, fwd PE 15.2). 1.0% is the honest size — the gate confirms 2.0% solo trips the 0.90 beta floor; 1.0% clears with no breaches. Advances the campaign 9→10 toward the 18-name floor as NEW selection, not a PEP/GIS top-up. The structural wall remains beta pinned at 0.90, not selection — the second 1.0% waits on a high-beta active name to open the budget honestly, and fund-level low-vol funding is a SPY trim, not the ETN lever.

GILD 1.0% (#60) clears clean post-PEP-sell — single-name mid-band, no breaches. The basket run dropped book beta 0.9113→0.9046, still inside the 0.90 floor with ~46bps headroom; the 2.0% Margaret wanted tips us under 0.90 and the gate vetoes it, so 1.0% is the honest max today. Loss path is benign: ~$9.8k line, a -15% gap loses ~$1.47k / ~15bps NAV, print 08-06 sits outside the holding window, and the -15% rel stop caps it. Bounded and wearable — no breached limit, no unwearable loss, not mine to block. Funding sequenced clean: PEP credit printed and settled first, net cash positive. Selection is Margaret's lane and the room converged. VOTE: approve

pep sell printed earlier, 77sh @ 142.03, name set at ~1.30%. gild 1.0% (#60) approved 4-0 by the voting seats, clears clean post-sell. working ~78sh @ ~125.45 (last close 06-17) for ~$9,810 notional on the open — gild not in any earnings freeze window, no resize-freeze conflict. sequence held: pep credit + 4,012 residual funds gild, net cash stays positive, no t+1 breach, and this finally retires the standing sub-floor sgov item without an spy trim. book to 10 active, breadth 9->10 toward the 18-name floor. no rejects, no halts, no breaks. ops doesn't vote.

FILLED — BOUGHT 79 GILD @ $124.21 (now ~1.01% of NAV), funded by trimming the SPY block. Book: 10 names, SPY ~79.3%, cash $14,796. This name is set — no need to re-table it.

Closing #60. The frame held all week — late-cycle, restrictive reals at 2.14, credit dead complacent at OAS 271, low-vol still ON — and we acted inside it, not against it. Today the floor finally opened: PEP printed 77sh @ $142.03 down to ~1.30%, and that credit funded GILD at 1.0% — bought 79sh @ $124.21, a real cash-flow defensive (39% op margin, $10B OCF, fwd PE 15.2, beta 0.33) and our first fresh selection breadth since #46. Book to 10 names, SPY core ~79.3%, beta 0.9046 with ~46bps of floor headroom. Carried 4-0. No veto stood; the only thing capped was size — 2.0% tips under the 0.90 floor, so 1.0% was the honest max. Open item still on the table: the second 1.0% is pre-committed to a higher-beta active name that unlocks the beta budget — I source it, Daniel sizes the pair. And CME is the new ugly on the tape (-4.05%, -10.1bps inception); not my name, but the room should check thesis-vs-tape before next sit-down. ABBV still re-rated — I want $205-210, print 07-30. That's the gavel. Lena, it's yours for the minutes.